205 related articles for article (PubMed ID: 32964632)
1. BODIPY-Based Photosensitizers as Potential Anticancer and Antibacterial Agents: Role of the Positive Charge and the Heavy Atom Effect.
Piskorz J; Porolnik W; Kucinska M; Dlugaszewska J; Murias M; Mielcarek J
ChemMedChem; 2021 Jan; 16(2):399-411. PubMed ID: 32964632
[TBL] [Abstract][Full Text] [Related]
2. Anchoring BODIPY photosensitizers enable pan-microbial photoinactivation.
Gu K; Lin G; Zhu Y; Ji X; Li J; Dong X; Zhao W
Eur J Med Chem; 2020 Aug; 199():112361. PubMed ID: 32408214
[TBL] [Abstract][Full Text] [Related]
3. Pyridinium-substituted tetraphenylethylene salt-based photosensitizers by varying counter anions: a highly efficient photodynamic therapy for cancer cell ablation and bacterial inactivation.
Xiong W; Wang L; Chen X; Tang H; Cao D; Zhang G; Chen W
J Mater Chem B; 2020 Jun; 8(24):5234-5244. PubMed ID: 32432307
[TBL] [Abstract][Full Text] [Related]
4. A glutathione-responsive photosensitizer with fluorescence resonance energy transfer characteristics for imaging-guided targeting photodynamic therapy.
Cao JJ; Zhang MS; Li XQ; Yang DC; Xu G; Liu JY
Eur J Med Chem; 2020 May; 193():112203. PubMed ID: 32197150
[TBL] [Abstract][Full Text] [Related]
5. Axially substituted silicon(IV) phthalocyanine and its quaternized derivative as photosensitizers towards tumor cells and bacterial pathogens.
Ömeroğlu İ; Kaya EN; Göksel M; Kussovski V; Mantareva V; Durmuş M
Bioorg Med Chem; 2017 Oct; 25(20):5415-5422. PubMed ID: 28807573
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeting BODIPY-loaded micelles as novel class of photosensitizer for photodynamic therapy.
Li M; Li X; Cao Z; Wu Y; Chen JA; Gao J; Wang Z; Guo W; Gu X
Eur J Med Chem; 2018 Sep; 157():599-609. PubMed ID: 30125721
[TBL] [Abstract][Full Text] [Related]
7. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.
Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F
Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525
[TBL] [Abstract][Full Text] [Related]
8. BODIPY-Tagged Platinum(II) Curcumin Complexes for Endoplasmic Reticulum-Targeted Red Light PDT.
Upadhyay A; Kundu P; Ramu V; Kondaiah P; Chakravarty AR
Inorg Chem; 2022 Jan; 61(3):1335-1348. PubMed ID: 34990135
[TBL] [Abstract][Full Text] [Related]
9. Light induced antimicrobial properties of a brominated boron difluoride (BF(2)) chelated tetraarylazadipyrromethene photosensitizer.
Frimannsson DO; Grossi M; Murtagh J; Paradisi F; O'Shea DF
J Med Chem; 2010 Oct; 53(20):7337-43. PubMed ID: 20879783
[TBL] [Abstract][Full Text] [Related]
10. Helical BODIPY Dyes as Heavy-Atom-Free Triplet Photosensitizers for Photodynamic Therapy of Cancer.
Mula S; Koli M
ChemMedChem; 2024 Jun; 19(11):e202400041. PubMed ID: 38359274
[TBL] [Abstract][Full Text] [Related]
11. Pyriplatin-Boron-Dipyrromethene Conjugates for Imaging and Mitochondria-Targeted Photodynamic Therapy.
Raza MK; Gautam S; Howlader P; Bhattacharyya A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Nov; 57(22):14374-14385. PubMed ID: 30376306
[TBL] [Abstract][Full Text] [Related]
12. BODIPYs bearing a dimethylaminopropoxy substituent for imaging and photodynamic inactivation of bacteria.
Palacios YB; Santamarina SC; Durantini JE; Durantini EN; Durantini AM
J Photochem Photobiol B; 2020 Nov; 212():112049. PubMed ID: 33065476
[TBL] [Abstract][Full Text] [Related]
13. Highly efficient near-infrared BODIPY phototherapeutic nanoparticles for cancer treatment.
Zhang Y; Yang Z; Zheng X; Chen L; Xie Z
J Mater Chem B; 2020 Jun; 8(24):5305-5311. PubMed ID: 32453332
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic inactivation of Staphylococcus aureus in the presence of aggregation-prone photosensitizers based on BODIPY used at submicromolar concentrations.
Navarro-Barreda D; de Llanos R; Miravet JF; Galindo F
J Photochem Photobiol B; 2022 Oct; 235():112543. PubMed ID: 36113260
[TBL] [Abstract][Full Text] [Related]
15. Highly Phototoxic Transplatin-Modified Distyryl-BODIPY Photosensitizers for Photodynamic Therapy.
Padrutt R; Babu V; Klingler S; Kalt M; Schumer F; Anania MI; Schneider L; Spingler B
ChemMedChem; 2021 Feb; 16(4):694-701. PubMed ID: 33164336
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells.
Karaman O; Almammadov T; Emre Gedik M; Gunaydin G; Kolemen S; Gunbas G
ChemMedChem; 2019 Nov; 14(22):1879-1886. PubMed ID: 31663667
[TBL] [Abstract][Full Text] [Related]
17. In vitro photodynamic treatment of cancer cells induced by aza-BODIPYs.
Malacarne MC; Banfi S; Caruso E
Photochem Photobiol Sci; 2020 Jun; 19(6):790-799. PubMed ID: 33856674
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activity of novel cationic BODIPY photosensitizers.
Caruso E; Banfi S; Barbieri P; Leva B; Orlandi VT
J Photochem Photobiol B; 2012 Sep; 114():44-51. PubMed ID: 22682365
[TBL] [Abstract][Full Text] [Related]
19. Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies.
Pucelik B; Paczyński R; Dubin G; Pereira MM; Arnaut LG; Dąbrowski JM
PLoS One; 2017; 12(10):e0185984. PubMed ID: 29016698
[TBL] [Abstract][Full Text] [Related]
20. BODIPY-vinyl dibromides as triplet sensitisers for photodynamic therapy and triplet-triplet annihilation upconversion.
Dartar S; Ucuncu M; Karakus E; Hou Y; Zhao J; Emrullahoglu M
Chem Commun (Camb); 2021 Jun; 57(49):6039-6042. PubMed ID: 34037007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
